Menu
Find People
Find Everything
About This Site
Edit My Profile
Login to Profiles
DIRECT2Experts
Help / FAQ
Keywords
Last Name
Institution
@uada.edu
@ualr.edu
@uapb.edu
@uark.edu
University of Arkansas for Medical Sciences
More Search Options
Announcement
You can now add alternative names!
Click here
to add other names that you've published under.
Co-Investigator
Overview
description
Phase II: To determine if patient-reported neck and shoulder function and related quality
of life (QOL) at 6 months after surgery using the Neck Dissection Impairment Index (NDII) is superior with Sentinel Lymph Node (SLN) biopsy compared to Elective Neck Dissection (END) for treatment of early-stage oral cavity squamous cell carcinoma (OCSCC) (cT1-2N0).
Phase III:
?? To determine if disease-free survival (DFS) is non-inferior with SLN biopsy
compared to END for treatment of early-stage OCSCC (cT1-2N0).
?? To determine if patient-reported neck and shoulder function and related QOL at 6
months after surgery using NDII is superior with SLN biopsy compared to END for treatment of early-stage OCSCC (cT1-2N0).
researcher role of
Vural, Emre
contributes to
NRG-HN006 (ClinicalTrials.gov NCT #04333537) RANDOMIZED PHASE II/III TRIAL OF SENTINEL LYMPH NODE BIOPSY VERSUS ELECTIVE NECK DISSECTION FOR EARLY-STAGE ORAL CAVITY CANCER